Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 4/2020

01.12.2020 | editorial

Treating head and neck cancer—A multidisciplinary effort

verfasst von: MD Gabriele Gamerith, Assoc. Prof. PD Dr. Thorsten Fuereder

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Head and neck (HNC) is the tenth most common cancer worldwide with over 650,000 new cases per year [ 13]. The major risk factors for development of squamous cell HNC comprise alcohol and tobacco consumption [ 4]. During the last few decades human papilloma virus (HPV) infection has been identified to contribute to the development of oropharyngeal HNC in a younger subgroup of patients [ 5]. This population shows a more favorable prognosis compared to HPV-negative disease [ 5]. Standard treatment options for HNC independent of HPV status include surgery, standard radiation, chemo- or bioradiation and chemotherapy. …
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. CrossRef
2.
Zurück zum Zitat Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489–501. CrossRef Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489–501. CrossRef
3.
Zurück zum Zitat Pfister DG, Ang KK, Brizel DM, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11:917–23. CrossRef Pfister DG, Ang KK, Brizel DM, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11:917–23. CrossRef
4.
Zurück zum Zitat World Health Organization, International Agency for Research on Cancer. Alcohol consumption and ethyl carbamate. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 96. 2010. pp. 3–1383. World Health Organization, International Agency for Research on Cancer. Alcohol consumption and ethyl carbamate. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 96. 2010. pp. 3–1383.
5.
Zurück zum Zitat Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches. Cancer Lett. 2014;351:198–205. CrossRef Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches. Cancer Lett. 2014;351:198–205. CrossRef
6.
Zurück zum Zitat Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73:187–90. CrossRef Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73:187–90. CrossRef
7.
Zurück zum Zitat Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995;104:946–54. CrossRef Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995;104:946–54. CrossRef
8.
Zurück zum Zitat Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol. 2010;21(Suppl 7):vii252–vii61. CrossRef Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol. 2010;21(Suppl 7):vii252–vii61. CrossRef
Metadaten
Titel
Treating head and neck cancer—A multidisciplinary effort
verfasst von
MD Gabriele Gamerith
Assoc. Prof. PD Dr. Thorsten Fuereder
Publikationsdatum
01.12.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00656-3